The closed system transfer devices market size is expected to advance at a CAGR of 15.20% during 2022–2030, to reach USD 3,516 million by 2030. This can be ascribed to the rising incidence of cancer and the increasing demand for CSTDs to tackle the harmful effects of drugs on healthcare workers.
According to the World Health Organization, around 10 million deaths occurred in 2020 due to cancer, which made it one of the leading causes of death worldwide. Also, the cases of cancer are increasing, due to which the demand for cancer-curing drugs is rising. With increasing standards for safety in healthcare facilities, healthcare workers are becoming more aware of the hazardous effects when exposed to drugs, such as antineoplastic, which can cause reproductive reactions, fatal malformation, skin rashes, leukemia, and many other problems. These drugs are not only hazardous to the receipt, administration, compounding, storage, disposal of sterile and non-sterile products, dispensing, and preparations but also harmful in a holistic way.
Many government organizations, such as the National Institute for Occupational Safety and Health (NIOSH) and the United States Pharmacopeia (USP), are also recommending the usage of CSTDs to eliminate the risk of these harmful reactions, as they not only help healthcare workers but also reduce the risk of surface contamination to drugs from aerosols that are generated by chemotherapeutic agents.
Based on technology, diaphragm-based devices hold the largest revenue share. This is due to the ease of using these devices and the amount of safety they provide. Also, they help in equalizing the pressure between vials and CSTD, and diaphragms collect both vapor and any sprays that may occur through the equalization of pressure within the system.
Whereas, the demand for compartmentalized CSTDs is expected to grow at the highest rate in the forecasted period, as there is no need for external additional pieces to these systems. Also, these devices compartmentalize the vapor behind the barrel head of a highly engineered syringe and transfer the vapor in between the system and the vial, and do the equalization of pressure using the sealed back portion of the syringe so that vapor and any sprays do not come out of the system.
In the closing mechanism segment, the color-to-color alignment system category is expected to grow at the highest rate in the coming years. This can be due to the high efficiency and low cost of these devices and the high usage of these devices in pressure equalization. Also, due to the unique structure of these devices, the chances of leaks, spills, and escape of vapor and aerosols are very low.
Globally, North America is the largest market for CSTDs, due to the presence of major manufacturers and the huge investment in the region toward healthcare. For instance, in the U.S., healthcare spending accounted for USD 4.3 trillion, which was 18.4% of the total gross domestic product in 2021. Due to the huge spending, the region has more buying capacity for these high-cost devices for the prevention of hazardous drugs.
The major closed system transfer devices market players are Becton, Dickinson and Company, ICU Medical, B. Braun Melsungen AG, JMS North America Corporation, Equashield, Simplivia Healthcare Ltd., Corvida Medical, Inc., Yukon Medical, CODAN Medizinische Gerate GmbH, Caragen Ltd., and Baxter International Inc.